MS-DRG v38 (FY 2021) Definitions Manual • DRG 846 - CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC

DRG Information as of MS-DRG v38 (FY 2021)

MDCMDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
MDC SubsectionChemotherapy without Acute Leukemia as Secondary Diagnosis
DRG Number846
DRG DescriptionCHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC
Surgical / Medical Medical

Table 5 for FY 2021

Weights2.669
Length of Stay (Geometric Mean)5.9
Length of Stay (Arithmetic Mean)7.9
Special Pay DRGNo
Post-Acute DRGNo

DRG Assignment Logic (From MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms Subsection Chemotherapy without Acute Leukemia as Secondary Diagnosis)

This DRG is a member of the subsection Chemotherapy without Acute Leukemia as Secondary Diagnosis. Patients who qualify for Chemotherapy without Acute Leukemia as Secondary Diagnosis will be grouped this DRG or one of the related DRGs according to the logic below.

View the requirements to qualify.

Quick Actions